Home688192 • SHA
add
Dizal Pharmaceutical Co Ltd
Previous close
¥48.17
Day range
¥46.07 - ¥48.68
Year range
¥32.72 - ¥51.15
Market cap
17.37B CNY
Avg Volume
2.10M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 21.94M | -57.13% |
Operating expense | 335.64M | -5.34% |
Net income | -298.31M | -7.01% |
Net profit margin | -1.36K | -149.62% |
Earnings per share | — | — |
EBITDA | -296.26M | 1.12% |
Effective tax rate | 31.15% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 808.30M | 8.03% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 437.25M | — |
Shares outstanding | 417.65M | — |
Price to book | 46.77 | — |
Return on assets | — | — |
Return on capital | -57.04% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -298.31M | -7.01% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Oct 27, 2017
Website
Employees
807
